In the midst of Nobel season, an op-ed piece in the New York Times says it's time to update the awards. Science and environmental writer Gabriel Popkin argues that science has changed since Alfred Nobel wrote his will in 1895. At that time, Popkin notes that the most exciting fields were physics, chemistry, and biology. "But the world of science has broadened and matured spectacularly since the late 1800s," he writes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.